Effects of changes in adult erythropoietin dosing guidelines on erythropoietin dosing practices, anemia, and blood transfusion in children on hemodialysis: findings from North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)
While adult hemodialysis (HD) patients have increased morbidity with higher target hemoglobin levels, similar findings have not been demonstrated in pediatric patients. We evaluated changes in transfusions, anemia frequency, and erythropoietin (epo) dosing among pediatric HD patients before, during, and after implementation of federal dialysis payment policies regarding epo dosing for adult HD patients.
This is a retrospective cohort study of pediatric HD patients enrolled in NAPRTCS. We evaluated need for transfusion, anemia, median hemoglobin, and median epo dose 6 months after starting HD in 3 eras: baseline (2003–2007), implementation (2008–2011), and post implementation (2012–2016). We used multivariate logistic regression models to evaluate potential differences in transfusion across the eras.
Six months after dialysis initiation, 12.6% of patients required transfusion pre-implementation, 17.9% during implementation, and 15.5% post implementation. Anemia occurred in 17.4% of patients pre, 23.5% during, and 23.8% post implementation, with median hemoglobin levels of 11.9 g/dL pre, 11 g/dL during, and 11 g/dL post implementation. Epo use was high across all 3 eras, but epo dosing decreased during and post implementation, despite more anemia during these periods. Odds of transfusion in implementation era compared with pre-implementation was 1.75 (95% CI 1.11–2.77) and odds of transfusion in post implementation era compared with pre was 1.19 (95% CI 0.71–1.98), controlling for age, race, gender, and prior transplant status.
During and following implementation of adult epo dosing guidelines, transfusion and anemia frequency increased in pediatric HD patients. Ideal target hemoglobin levels for pediatric dialysis patients warrant further study.
KeywordsAnemia Hemodialysis Erythropoietin Transfusion Children
We would like to acknowledge the NAPRTCS study group and participants for making this research possible.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 1.Locatelli F, Nissenson AR, Barrett BJ, Walker RG, Wheeler DC, Eckardt KU, Lameire NH, Eknoyan G (2008) Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 74:1237–1240. https://doi.org/10.1038/ki.2008.299 CrossRefPubMedGoogle Scholar
- 9.Marcdante K, Kliegman R (2019) Hematology assessment. In: Marcdante K, Kliegman R (eds) Nelson essentials of pediatrics, 8th edn. Elsevier, Philadelphia, pp 563–566Google Scholar
- 10.Borzych-Duzalka D, Bilginer Y, Ha IS, Bak M, Rees L, Cano F, Munarriz RL, Chua A, Pesle S, Emre S, Urzykowska A, Quiroz L, Ruscasso JD, White C, Pape L, Ramela V, Printza N, Vogel A, Kuzmanovska D, Simkova E, Muller-Wiefel DE, Sander A, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (IPPN) Registry (2013) Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol 24:665–676. https://doi.org/10.1681/ASN.2012050433 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Scornik JC, Bromberg JS, Norman DJ, Bhanderi M, Gitlin M, Petersen J (2013) An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival. BMC Nephrol 14:217. https://doi.org/10.1186/1471-2369-14-217 CrossRefPubMedPubMedCentralGoogle Scholar
- 14.North American Pediatric Renal Trials and Collaborative Studies (2008) 2008 Annual ReportGoogle Scholar